You are here

Article Text

Article menu

Download PDFPDF

Review series
α1-Antitrypsin deficiency · 5: Intravenous augmentation therapy: current understanding
Free
  1. J K Stoller1,
  2. L S Aboussouan2
  1. 1Division of Medicine, Section of Respiratory Therapy, Cleveland Clinic Lerner School of Medicine, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
  2. 2Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland OH 44195, USA
  1. Correspondence to:
    Dr J K Stoller
    Division of Medicine, Section of Respiratory Therapy, Cleveland Clinic Lerner School of Medicine, Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA; stollejccf.org

Abstract

The biochemical and clinical efficacy of intravenous augmentation therapy in α1-antitrypsin deficiency is reviewed, adverse events experienced with this treatment are considered, and its cost effectiveness is discussed.

  • α1-antitrypsin deficiency
  • augmentation therapy

https://doi.org/10.1136/thx.2003.006544

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text